Development and Validation of Prediction Models for Exacerbation, Frequent Exacerbations and Severe Exacerbations of Chronic Obstructive Pulmonary Disease: A Registry Study in North China

References

• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163–2196. doi: 10.1016/S0140-6736(12)61729-2.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi: 10.1016/S0140-6736(12)61728-0.
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi: 10.1016/S2213-2600(18)30103-6.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi: 10.1016/S0140-6736(07)61382-8.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi: 10.1164/ajrccm.157.5.9709032.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi: 10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Müllerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007. doi: 10.1378/chest.14-0655.
   PubMed Web of Science ®Google Scholar
• Baroi S, McNamara RJ, McKenzie DK, et al. Advances in remote respiratory assessments for people with chronic obstructive pulmonary disease: a systematic review. Telemed J E Health. 2018;24(6):415–424. doi: 10.1089/tmj.2017.0160.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee CH, Lee MG, et al. Acute exacerbation according to GOLD 2017 categories in patients with chronic obstructive pulmonary disease. Arch Bronconeumol (Engl Ed). 2019;55(8):414–420. doi: 10.1016/j.arbres.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Le LAK, Johannessen A, Hardie JA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:1639–1655. doi: 10.2147/COPD.S194019.
   PubMed Web of Science ®Google Scholar
• Erol S, Sen E, Gizem Kilic Y, et al. Does the 2017 revision improve the ability of GOLD to predict risk of future moderate and severe exacerbation? Clin Respir J. 2018;12(8):2354–2360. doi: 10.1111/crj.12914.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi: 10.1016/S2213-2600(15)00106-X.
   PubMed Web of Science ®Google Scholar
• Kang HS, Kim SK, Kim YH, et al. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulm Med. 2021;21(1):74. doi: 10.1186/s12890-021-01443-4.
   PubMed Web of Science ®Google Scholar
• Gong C, Yang Y, Chen M, et al. Effect of procalcitonin on the prognosis of patients with COPD. Biomed Rep. 2020;12(6):313–318.
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The acute COPD exacerbation prediction tool (ACCEPT): a modelling study. Lancet Respir Med. 2020;8(10):1013–1021. doi: 10.1016/S2213-2600(19)30397-2.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi: 10.1164/rccm.201701-0218PP.
   PubMed Web of Science ®Google Scholar
• P, Voors AA, Anker SD, Bueno H, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi: 10.1093/eurheartj/ehw128.
   PubMedGoogle Scholar
• Vitacca M, Paneroni M. Rehabilitation of patients with coexisting COPD and heart failure. COPD. 2018;15(3):231–237. doi: 10.1080/15412555.2018.1468427.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2021 REPORT.
   Google Scholar
• Lee HW, Park J, Jo J, et al. Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis. PLoS Med. 2019;16(11):e1002958. doi: 10.1371/journal.pmed.1002958.
   PubMed Web of Science ®Google Scholar
• Martínez-Gestoso S, García-Sanz MT, Calvo-Álvarez U, et al. Variability of blood eosinophil count and prognosis of COPD exacerbations. Ann Med. 2021;53(1):1152–1158.
   PubMed Web of Science ®Google Scholar
• Rivero-Yeverino D. Spirometry: basic concepts. Rev Alerg Mex. 2019;66(1):76–84. doi: 10.29262/ram.v66i1.536.
   PubMedGoogle Scholar
• Chen C, He Y, Chen Q, et al. A specific subtype of chronic obstructive pulmonary disease classified by forced vital capacity. J Thorac Dis. 2018;10(12):6547–6556. doi: 10.21037/jtd.2018.12.06.
   PubMed Web of Science ®Google Scholar
• Gao N, Xu W, Ji J, et al. Lung function and systemic inflammation associated with short-term air pollution exposure in chronic obstructive pulmonary disease patients in Beijing, China. Environ Health. 2020;19(1):12. doi: 10.1186/s12940-020-0568-1.
   PubMed Web of Science ®Google Scholar
• Karloh M, Fleig Mayer A, Maurici R, et al. The COPD assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest. 2016;149(2):413–425. doi: 10.1378/chest.15-1752.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi: 10.1183/09031936.00102509.
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Kostikas K, Roche N, et al. Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study. Respir Res. 2020;21(1):93. doi: 10.1186/s12931-020-01354-8.
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Konstantinidis AK, et al. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. doi: 10.1136/bmj.l5358.
   PubMed Web of Science ®Google Scholar